AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma

NCT04881032 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Polysiloxane Gd-Chelates based nanoparticles (AGuIX)
RADIATION: radiotherapy
DRUG: Temozolomide

Sponsor

Centre Jean Perrin

Collaborators

[object Object]